Dose-escalation Normalization

Dose-Escalation Normalization is a methodological framework in pharmacological and clinical research that standardizes dosage adjustments across subjects or cohorts by scaling administration levels relative to a defined reference dose, thereby enabling comparative analysis of efficacy and safety responses in escalating dose regimens.

1

Publications

47

Citations

19

Authors

4

Institutions

Publications per year

2017–2026

0

Authors

19

  1. SP
    Stephen P. Spielberg

    Hospital for Sick Children, Canada

    1 publications · 47 citations

    1

    h-index

  2. HN
    Ha Nguyen

    Merck & Co., Inc., Rahway, NJ, USA (United States), United States

    1 publications · 47 citations

    1

    h-index

  3. KB
    Kathryn Blake

    Nemours Children's Health System, United States

    1 publications · 47 citations

    1

    h-index

  4. PL
    Patrick Larson

    Merck & Co., Inc., Rahway, NJ, USA (United States), United States

    1 publications · 47 citations

    1

    h-index

  5. NM
    N. Michiels

    Merck & Co., Inc., Rahway, NJ, USA (United States), United States

    1 publications · 47 citations

    1

    h-index

1–5 of 19

Venues

  1. The Journal of Clinical Pharmacology

    1 publications · 47 citations

    1

    h-index

1–2